Impact of psychoeducation on the relapse rate of schizophrenic patients: about a study in Algiers hospital middle

  • S SEHIM Professeur à l’université Alger 1, Faculté de Médecine.
  • K BAKIR Maître de conférences A à l’université Alger 1, Faculté de Médecine.
  • M KIHAL Maître-assistante à l’université de Blida, Faculté de Médecine
  • M NEDJARI Professeur à l’université Alger 1, Faculté de Médecine
DOI: https://doi.org/10.34118/amr.v1i4.2804
Keywords: Observance Relapse, Schizophrenia, Psychoéducation

Abstract

Introduction: Relapse is not rare, and its frequency and speed of onset often originate in defective drug compliance. Facilitating compliance is therefore an important issue; this requires a special approach, centered on well-defined protocols. In recent years, programs of adherence combined with those of therapeutic education, implement services to increase the capacity of patients to support themselves. The objective of our research work was to set up a psychoeducation program with neuroleptic treatment (Lieberman's program) and to evaluate its impact on the rate of relapse at two years. Materials and methods: This is a prospective, randomized, comparative study that involved 300 man and woman patients aged 16 to 60 and older who met the DSM-5 criteria for schizophrenia, recruited in hospitalization services and consultations with clinical evaluation using the PANSS scale and an evaluation adherence treatment using the MARS scale. The patients were randomized into two groups of one hundred and fifty, depending on the type of care: psychoeducational group versus control group. Surveillance parameters were statistically comparable in both inclusion groups (relapse / re-hospitalization and clinic). The results did not show any significant differences between the two groups. From our work. We propose some hypothesis about the inefficacy of the therapeutic education program on improving adherence and some recommendations

References

[1] Nicolas Franck. Psychoéducation et troubles de l’insight dans la schizophrénieHow to involve patients with schizophrenia in their treatment using psychoeducation. La Presse Médicale. Volume 45, Issue 9, September 2016, Pages 742-748 [2] Petitjean F, Salomé F, Villamaux M and al. The impact of psychoeducative program (PACT) on the subjective quality of life of patients with schizophrenia. Intl J of Neuropsychopharmacology 2004;7, Supl.1, 217. [3] American Psychiatric Association. Practice guideline for the treatement of patient with schizophrenia. 2ndeddition. Association AP (American Psychiatric Assocition): Washington; 2004. [4] Atkinson, J., Coia, D., Gilmour, W., & Harper , J.. The impact of education groups for people with schizophrenia on social functioning and quality of life. British Journal of Psychiatry, (1996) 168:199–204. [5] Association Américaine de Psychiatrie 2013. Manuel diagnostique et statistique des troubles mentaux, 5e éd ; trad.Fr, Paris Masson, 2015. a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241–7. [6] Kay, S.R., Fiszbein, A. and Opler, L.A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276. [7] Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241–7. [8] Lieberman JA, Alvir JM, Koreen A and al. Psychobiologic Correlates of treatement Response in Schizophrenia. Neuropsychopharmacology 1996, 14 (3 suppl) : 13S-21S. [9] Csernansky JG, Schuchart EK. Relapse and Rehospitalisation Rates in Patients with Schizophrenia : Effects of Second Generation Antipsychotics. CNS Drugs 2002, 16 (7) : 47384. [10] Bechdolf A., Knost B., Kuntermann C and al. A randomized comparison of group cognitive-behavioural therapy and group
psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica. July 2004. Volume110, Issue1. Pages 21-28 [11] Buchkremer, G.; Klingberg, S.; Holle, R. and al. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: Results of a 2-year follow-up. Ada Psychiatrica Scandinavica, 96:483-491, 1997. [12] Pekkala, E. & Merinder, L. Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews, (2002). Issue 2. [13] Pilling, S., Bebbington, P., Kuipers, E and al. Psychological treatments in schizophrenia: I. Meta analysis of family intervention and cognitive-behaviour therapy. Psychological Medicine . (2002) 32, 763–782. [14] Gabriele Pitschel-Walz , Josef Bäuml and al. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study . J Clin Psychiatry. 2006 Mar;67(3):443-52. [15] Aguglia E, Pascolo-Fabrici E, Bertossi F and al. Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network. Clin Pract and Epid in Mental Health 2007, 3, 7 : 1-12. [16] Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2000;(4):CD002831 [17] LincolnK T.M, WilhelmK, Nestoriuc Y.. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a metaanalysis Schizophr Res. Volume 96, Issues 1–3, November 2007, Pages 232-245 [18] Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011 Jun 15; 2011(6):CD002831. [19] Zhao S, Sampson S, Xia J, Jayaram MB. Psychoeducation (brief) for people with serious mental illness. Cochrane Database Syst Rev. 2015 Apr 9;(4):CD010823. [20] Kampman O et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res (2002) [21] Abbadi S. Psychoéducation et schizophrénie : aléa d’une propédeutique. Inf Psychiatr 2005 ; 81 : 709-13
[22] Klingberg, S., Buchkremer, G., Holle, R. and al. (1999). Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients--results of a 2-year follow-up. European Archives of Psychiatry and Clinical Neuroscience. 249(2), 66-72. [23] Chabannes, J.-P., Bazin , N., Leguay , P and al. (2009). Intérêt du programme éducationnel Soleduc® pour la prévention des rechutes dans la schizophrénie. Annales médicopsychologiques, 167:115–8. [24] Chabannes JP, Bazin N, Leguay D and al. Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug. European Psychiatry 2008, 23 : 8-13. [25] Shepherd M, Watt D, and al. The natural history of schizophrenia: a five year follow-up in a representative sample of schizophrenics. Psychol Med 1989; 15:1–15
Published
2022-12-31
Issue
Vol 1 No 4 (2022)
Section
original article

Copyright (c) 2022 Avicenna Medical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.